China Bets Big on Brain-Computer Interfaces With NeuroXess
Shanghai startup NeuroXess advances to human trials as Beijing backs China's push to dominate brain-computer interfaces.
China is making a serious play to become a global leader in brain-computer interfaces. Shanghai-based startup NeuroXess is now moving into human trials, backed by Beijing's support and a regulatory environment that's greasing the wheels.
The company is part of a broader national push where looser regulation and fresh investment are helping Chinese firms accelerate BCI development at a pace that could rival Western competitors.
Beijing's backing isn't subtle. The government sees brain-computer interfaces as a strategic technology worth throwing weight behind, and startups like NeuroXess are the direct beneficiaries.
The combination of state support, willing capital, and a lighter regulatory touch is creating conditions for Chinese BCI companies to move fast — potentially faster than their counterparts navigating stricter oversight elsewhere. Human trials are the critical next step, and NeuroXess is already there.